Guidant Anticipating Less Volatility In Coronary Stent Market In 2000
This article was originally published in The Gray Sheet
Guidant expects its launch of the Tristar coronary stent later this year to further enhance the company's leading market share position.
You may also be interested in...
The coronary stent market seems to be maturing, as new product introductions offer fewer distinctions between successive product generations, according to clinicians.
Europe's largest online pharmacy is calling for online sales of OTC medicines to be allowed in its home market Switzerland, to increase the supply of crucial products to help people manage the symptoms of COVID-19, such as headaches, fever, diarrhoea, coughs, colds or nausea.
Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.